by Jordana Choucair | Nov 5, 2021 | Life Sciences
The U.S. canceled a $600 million deal with Emergent BioSolutions, the vaccine manufacturer that ruined millions of Johnson & Johnson COVID-19 doses. The cancellation comes after Emergent’s manufacturing facilities in Baltimore were found to have produced millions...
by Jordana Choucair | Nov 5, 2021 | Life Sciences
Pfizer announced that its antiviral COVID-19 pill cut the risk of hospitalizations and deaths by 89 percent compared to those who received a placebo. The pharmaceutical company reported that three of the 389 people who received the drug (0.8 percent) were hospitalized...
by Jordana Choucair | Nov 5, 2021 | Inequities and SDOH
The National Institutes of Health has started collecting data for one initiative in their All of Us project research program, focused on understanding more about the social determinants of health (SDOH). Respondents will share information on neighborhood safety,...
by Jordana Choucair | Nov 5, 2021 | Health IT
Google parent company Alphabet Inc. launched a new firm to use artificial intelligence to “reimagine the entire drug discovery process from the ground up.” The company, called Isomorphic Labs, will build off of work from Alphabet’s research lab that has used...
by Jordana Choucair | Nov 5, 2021 | D.C. News
The House today will vote on President Biden’s $1.85 trillion spending package as well as the $1 trillion bipartisan infrastructure bill. The House Rules Committee met late Thursday night to advance the final text of the bill that would expand health care, childcare,...
by Jordana Choucair | Nov 5, 2021 | Access & Coverage
Texas announced an additional $310 million in funding for the emergency Supplemental Nutrition Assistance Program (SNAP) for November. The move maxes out the allowable amount of benefits for recipients based on family size and will give more than 1.5 million...
Recent Comments